Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Plucked hair follicles can help diagnose scalp lupus.

Plant extracts can help remove permanent makeup without lasers.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

A woman's hair loss led to discovering she had lupus.

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Cross-cultural plant knowledge can improve skin treatments.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Early diagnosis and a strict gluten-free diet are crucial for children with celiac disease to improve symptoms.

Hydrogel-forming microneedles are promising for safe, efficient, and controlled drug delivery through the skin.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Sterculia foetida seed extract shows promise for therapeutic use due to its anti-inflammatory and pain-relief properties.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

More precise, personalized therapies are needed for autoimmune diseases.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.